Biohaven Pharmaceutical Holding Co Ltd. (BHVN) has 175 open-market insider trades by 19 insiders since 2017. The most active filer is Gregory Bailey, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| John W. Childs | Dir | — | 24 | $167.1M | 2025-11-13 |
| Declan Doogan | Dir | — | 25 | $68.4M | 2021-11-29 |
| Gregory Bailey | Dir | — | 26 | $63.3M | 2025-11-13 |
| Vlad Coric | CEO | — | 17 | $62.3M | 2026-01-05 |
| Robert Berman | — | — | 26 | $45.2M | 2020-07-08 |
| James Engelhart | CFO | — | 10 | $10.8M | 2022-10-03 |
| Albert Cha | Dir | — | 1 | $8.0M | 2018-03-14 |
| Portage Biotech Inc. | — | — | 4 | $7.4M | 2018-01-23 |
| Kimberly Gentile | VP | — | 12 | $6.3M | 2026-01-05 |
| Elyse Stock | — | — | 3 | $6.2M | 2022-10-03 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| George C. Clark | CAO & VP | Buy | $145K | 2025-11-17 |
| Vlad Coric | CEO | Buy | $5.0M | 2025-11-13 |
| John W. Childs | Director | Buy | $50.0M | 2025-11-13 |
| Gregory Bailey | Director | Buy | $3.0M | 2025-11-13 |
| John W. Childs | Director | Buy | $864K | 2025-03-04 |
| John W. Childs | Director | Buy | $892K | 2025-03-04 |
Companies that share insiders with BHVN, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| John W. Childs | Director | Buy | $2.1M | 2024-12-30 |
| John W. Childs | Director | Buy | $1000K | 2024-10-02 |
| Gregory Bailey | Director | Buy | $221K | 2024-09-24 |
| John W. Childs | Director | Buy | $1.0M | 2024-07-18 |
| Bruce Car | CSO | Buy | $1.0M | 2024-06-17 |
| John W. Childs | Director | Buy | $996K | 2024-05-30 |
| Gregory Bailey | Director | Buy | $1.0M | 2024-05-13 |
| John W. Childs | Director | Buy | $1.0M | 2024-05-13 |
| Gregory Bailey | Director | Buy | $2.0M | 2024-04-24 |